Click here for search
Click here for search

The Press Room

APC Information Center:
Shortage Drug Compounding and GLP-1s

Frame 104 (1)

General pharmacy compounding background information

Video Resources

How to be confident your compounded drugs are legit.

Scott Brunner

Additional Resources

1
APC Town Hall | Lawsuits, Marketing Claims, & Best Practices
2
ABC News | Shot in the Dark: Weight Loss Injection Wars

APC Responds to Lawmakers’ Concerns Over Marketing of Compounded Medications

Lawmakers have raised concerns with the FDA regarding Hims & Hers recent Super Bowl ad and its implications for compounded medication marketing. APC CEO Scott Brunner responds with a detailed statement, emphasizing the regulatory distinctions between compounded drugs and FDA-approved pharmaceuticals, the role of the FTC in oversight, and APC’s commitment to best practices in marketing transparency. Read the full statement to stay informed on this evolving discussion.

Read the Full Statement

On Thursday, February 20, APC is hosting a webinar that will provide an in-depth look at best practices for ethically marketing compounding services and products while adhering to regulatory requirements. Register today to learn more about what is and is not allowed in marketing compounded medications.

Register for the Webinar

APC-Marketing-sm

 

Connect with an APC Team Member: Reporter's Inquiry Form

 

 

nosymbol2

Tell FDA: Nonsense!

Drugmakers have asked FDA to prohibit compounded GLP-1s